| mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.003 |
0.9 |
| mRNA |
TAK-715 |
GDSC1000 |
pan-cancer |
AAC |
-0.0026 |
0.9 |
| mRNA |
BRD-K41597374 |
CTRPv2 |
pan-cancer |
AAC |
0.0027 |
0.9 |
| mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.003 |
0.9 |
| mRNA |
Erlotinib |
FIMM |
pan-cancer |
AAC |
-0.012 |
0.9 |
| mRNA |
T0901317 |
GDSC1000 |
pan-cancer |
AAC |
-0.0023 |
0.9 |
| mRNA |
spautin-1 |
CTRPv2 |
pan-cancer |
AAC |
0.0027 |
0.9 |
| mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0025 |
0.9 |
| mRNA |
VNLG/124 |
GDSC1000 |
pan-cancer |
AAC |
0.0022 |
0.9 |
| mRNA |
lomeguatrib |
CTRPv2 |
pan-cancer |
AAC |
-0.0026 |
0.9 |